Literature DB >> 1435361

[Complement C3 and C4 levels in serum from acute viral hepatitis].

F T Ozer1, A Barut, A Inal, A Hacibektaşoğlu.   

Abstract

Serial measurements of C3 and C4 complement components were performed in 50 patients with acute, uncomplicated viral hepatitis, in the beginning of the symptoms and in the peaks of serum transaminases. There were 17 patients diagnosed as having Hepatitis A virus (HAV) infection and 33 patients diagnosed as having Hepatitis B virus (HBV) infection. There were 4 women and 46 men with a mean age of 22.1 years. In the sera of 50 healthy control subjects serum C3 and C4 complement components measured, this group was composed of 15 women and 35 men with a mean age of 26 years. The complement component levels were observed to be reduced in both viral infections, where the reduction in C3 serum concentration was found to be statistically significant but reduction in C4 serum concentration was not.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1435361

Source DB:  PubMed          Journal:  Mikrobiyol Bul        ISSN: 0374-9096            Impact factor:   0.622


  3 in total

1.  Upregulation of microRNA-146a by hepatitis B virus X protein contributes to hepatitis development by downregulating complement factor H.

Authors:  Jun-Feng Li; Xiao-Peng Dai; Wei Zhang; Shi-Hui Sun; Yang Zeng; Guang-Yu Zhao; Zhi-Hua Kou; Yan Guo; Hong Yu; Lan-Ying Du; Shi-Bo Jiang; Yu-Sen Zhou
Journal:  MBio       Date:  2015-03-24       Impact factor: 7.867

2.  Complement System as a Target for Therapies to Control Liver Regeneration/Damage in Acute Liver Failure Induced by Viral Hepatitis.

Authors:  Juliana Gil Melgaço; Carlos Eduardo Veloso; Lúcio Filgueiras Pacheco-Moreira; Claudia Lamarca Vitral; Marcelo Alves Pinto
Journal:  J Immunol Res       Date:  2018-10-08       Impact factor: 4.818

3.  Hepatitis B virus X protein binding to hepsin promotes C3 production by inducing IL-6 secretion from hepatocytes.

Authors:  Mingming Zhang; Jianxin Gu; Chunyi Zhang
Journal:  Oncotarget       Date:  2016-02-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.